Active Ingredient(s):Isosorbide Dinitrate + Hydralazine Hydrochloride FDA Approved: * June 23, 2005 Pharm Company: *NITROMED Category:Chest Pain (Angina)
Isosorbide dinitrate/hydralazine is a fixed dose combination drug treatment specifically approved by the US FDA to be used to treat self-identified black people with congestive heart failure. It is a combination of hydralazine (an antihypertensive) and isosorbide dinitrate (a vasodilator). It is the first race-based prescription drug in the United States.: 7
The combination preparation is marketed in the United States under ...
* May have multiple approval dates, manufacturers, or labelers. 6 Discussions